Juvenile dermatomyositis: New insights and new treatment strategies

34Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Juvenile dermatomyositis (JDM) is a rare but complex and potentially life-threatening autoimmune disease of childhood, primarily affecting proximal muscles and skin. Although the cause of JDM remains unknown it is clear that genetic and environmental influences play a role in the aetiology. In contrast to adults with dermatomyositis, children with JDM are more likely to have complications that are thought to indicate a vasculopathic process, such as severe skin disease, with ulceration or calcinosis, gut vasculopathy or central nervous system disease. New treatments are much needed and are becoming available and being tested through international multicentre trials. This review will focus on recent insights into pathogenesis, the assessment of the disease in children and the modern approach to its treatment. © 2012, SAGE Publications. All rights reserved.

Cite

CITATION STYLE

APA

Martin, N., Li, C. K., & Wedderburn, L. R. (2012). Juvenile dermatomyositis: New insights and new treatment strategies. Therapeutic Advances in Musculoskeletal Disease, 4(1), 41–50. https://doi.org/10.1177/1759720X11424460

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free